Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology-Reference-Cited by-同舟云学术

Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology

Published:2020-06-08 Issue:2 Volume:87 Page:227-236
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Menz Bradley D.¹^ORCID,Stocker Sophie L.²³^ORCID,Verougstraete Nick⁴⁵,Kocic Danijela²³,Galettis Peter⁶,Stove Christophe P.⁵^ORCID,Reuter Stephanie E.⁷^ORCID

Affiliation:

1. SA Pharmacy Flinders Medical Centre Adelaide SA Australia

2. Department of Clinical Pharmacology & Toxicology St Vincent's Hospital Sydney NSW Australia

3. St. Vincent's Clinical School University of New South Wales Sydney NSW Australia

4. Department of Laboratory Medicine Ghent University Hospital Ghent Belgium

5. Laboratory of Toxicology, Faculty of Pharmaceutical Sciences Ghent University Ghent Belgium

6. Faculty of Health and Medicine University of Newcastle Callaghan NSW Australia

7. UniSA Clinical & Health Sciences University of South Australia Adelaide SA Australia

Funder

Cancer Council South Australia

Cancer Council NSW

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14372

Reference107 articles.

1. Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study

2. Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients

3. Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

4. Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

5. Therapeutic drug monitoring in cancer – Are we missing a trick?

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2024-04-17

2. Economic evaluation of personalized vs. standard dosing of 5‐fluorouracil in first‐line chemotherapy for metastatic colorectal cancer in Australia;British Journal of Clinical Pharmacology;2024-02-12

3. A Survey of Generative Adversarial Networks for Synthesizing Structured Electronic Health Records;ACM Computing Surveys;2024-01-22

4. Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance;Pharmaceuticals;2024-01-12

5. Overview of therapeutic drug monitoring and clinical practice;Talanta;2024-01